Laura Okpala

Company: Gilead Sciences

Job title: Executive Director, US Reimbursement Policy

Seminars:

Gaining In-Depth Insights into the US Market Landscape to Uncover Hidden Challenges & Anticipate Future Benefits for Strategic Decision-Making 4:00 pm

How to tackle patient enrolment hurdles such as co-pay concerns or fear to enhance treatment onboarding? Lessons learned about the barriers to utilization posing difficulties to broad access and utilization of cell and gene therapies as we prepare for more of these products to enter the market Assessing the potential value-based agreements, such as CMMI’s…Read more

day: Conference Day One

Evaluating Inpatient Payment Systems to Address Under-Reimbursement Challenges & Enhance Access to Cell Therapies 11:30 am

Inpatient delivery and profitability: why therapies are not profitable when delivered in the hospital setting Separating the drug from the service: the challenge of underpayment of services and offsetting the loss through the drug price Bundled payments in the inpatient delivery leading to inadequate reimbursementRead more

day: Conference Day Two